Facilitated PCI    Panic disorder and risk of new onset coronary heart disease, acute myocardial infarction, and cardiac mortality: cohort study using the general practice research database Eur Heart J (2008) 29; 2981-8 K. Walters, G. Rait, I. Petersen, R. Williams and I. Nazareth Comparison of outcomes and safety of "facilitated" versus primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction Am J Cardiol (2009) 103; 316-21 R. G. McKay, M. R. Dada, J. F. Mather, R. R. Mennet, D. J. Murphy, K. W. Maloney, J. A. Hirst and F. J. Kiernan Adverse outcomes in fibrinolytic-based facilitated percutaneous coronary intervention: insights from the ASSENT-4 PCI electrocardiographic substudy Eur Heart J (2008) 29; 871-9 M. A. McDonald, Y. Fu, U. Zeymer, G. Wagner, S. G. Goodman, A. Ross, C. B. Granger, F. Van de Werf and P. W. Armstrong Multicenter randomized trial of facilitated percutaneous coronary intervention with low-dose tenecteplase in patients with acute myocardial infarction: The Athens PCI trial Catheter Cardiovasc Interv (2009) J. Kanakakis, J. N. Nanas, E. P. Tsagalou, G. D. Maroulidis, S. G. Drakos, A. S. Ntalianis, P. Tzoumele, E. Skoumbourdis, P. Charbis, S. Rokas and M. Anastasiou-Nana Facilitated PCI in patients with ST-elevation myocardial infarction N Engl J Med (2008) 358; 2205-17 S. G. Ellis, M. Tendera, M. A. de Belder, A. J. van Boven, P. Widimsky, L. Janssens, H. R. Andersen, A. Betriu, S. Savonitto, J. Adamus, J. Z. Peruga, M. Kosmider, O. Katz, T. Neunteufl, J. Jorgova, M. Dorobantu, L. Grinfeld, P. Armstrong, B. R. Brodie, H. C. Herrmann, G. Montalescot, F. J. Neumann, M. B. Effron, E. S. Barnathan and E. J. Topol Four-year clinical follow-up of the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital registry Am J Cardiol (2008) 101; 1105-11 J. Daemen, N. Kukreja, P. H. van Twisk, Y. Onuma, P. P. de Jaegere, R. van Domburg and P. W. Serruys GCH1 haplotype determines vascular and plasma biopterin availability in coronary artery disease effects on vascular superoxide production and endothelial function J Am Coll Cardiol (2008) 52; 158-65 C. Antoniades, C. Shirodaria, T. Van Assche, C. Cunnington, I. Tegeder, J. Lotsch, T. J. Guzik, P. Leeson, J. Diesch, D. Tousoulis, C. Stefanadis, M. Costigan, C. J. Woolf, N. J. Alp and K. M. Channon Elevated plasma fibrinogen and diabetes mellitus are associated with lower inhibition of platelet reactivity with clopidogrel J Am Coll Cardiol (2008) 52; 1052-9 L. Ang, V. Palakodeti, A. Khalid, S. Tsimikas, Z. Idrees, P. Tran, P. Clopton, N. Zafar, G. Bromberg-Marin, S. Keramati and E. Mahmud